Zevra Therapeutics

ZVRA

----

Current ValuationThe current P/E ratio is 10.18, above the reasonable range, cheaper than 11.2% of the time in the past 5 years, and the industry ranks 12/256, the industry Median -1.11.

10.18xP/E

Stock price$9.81Earnings per share$0.96

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

0295887116

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x20x40x60x80x100x

P/E ratio
Name/Symbol
BMYUSBristol Myers Squibb	13.53x	52.98%	$125.59B
GSKUSGSK	16.08x	16.02%	$103.41B
OTSKYUSOtsuka Pharmaceutical	16.06x	--	$41.60B
ZTSUSZoetis	12.70x	6.54%	$33.48B
DSNKYUSDaiichi Sankyo	19.33x	--	$32.48B
ALPMYUSAstellas Pharma	12.26x	--	$28.60B
JAZZUSJazz Pharma	14.77x	266.27%	$13.89B
OPHLYUSOno Pharmaceutical	15.24x	--	$7.43B
INDVUSIndivior Pharmaceuticals	11.43x	126.83%	$4.07B
HYPMYUSHypera S.A.	11.53x	--	$3.80B
OGNUSOrganon	17.28x	211.11%	$3.61B
SNPHYUSSanten Pharmaceutical	14.54x	--	$3.59B
PBHUSPrestige Brands	13.16x	7.48%	$2.26B
HRMYUSHarmony Biosciences	11.61x	45.72%	$2.10B
ANIPUSANI Pharma	16.38x	51.20%	$1.63B
PAHCUSPhibro Animal Health	15.80x	27.16%	$1.58B
GTBIFUSGreen Thumb Industries Inc.	11.59x	--	$1.47B
CRONUSCronos	17.64x	944.31%	$1.23B
AMPHUSAmphastar Pharma	13.61x	6.90%	$1.07B
COLLUSCollegium Pharma	15.60x	35.45%	$747.48M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.